| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1001 |
PSU20 IS THERE INDICATION BIAS OF RETROSPECTIVE OBSERVATIONAL STUDY?
|
Choi, J.E.
|
|
2011
|
14 |
3 |
p. A89-A90
nvt p.
|
artikel
|
| 1002 |
PSU16 LAPAROSCOPIC SUPRACERVICAL HYSTERECTOMY VERSUS LAPAROSCOPIC-ASSISTED VAGINAL HYSTERECTOMY: POST-SURGICAL OUTCOMES AND COSTS
|
Waters, H.
|
|
2011
|
14 |
3 |
p. A89-
1 p.
|
artikel
|
| 1003 |
PSU3 LONG-TERM CLINICAL EFFECTIVENESS AND STABILITY OF LASIK AND SURFACE ABLATION IN KOREA: A SYSTEMATIC REVIEW APPROACH
|
Lee, N.R.
|
|
2011
|
14 |
3 |
p. A86-
1 p.
|
artikel
|
| 1004 |
PSU5 LONG-TERM CLINICAL SAFETY OF LASIK AND SURFACE ABLATION IN SOUTH KOREA THROUGH LINKAGE OF RETROSPECTIVE COHORT AND NATIONWIDE CLAIMS DATABASE
|
Lee, E.J.
|
|
2011
|
14 |
3 |
p. A87-
1 p.
|
artikel
|
| 1005 |
PSU13 MORBID OBESITY AND HEALTH RELATED QUALITY OF LIFE
|
Tayyem, R.
|
|
2011
|
14 |
3 |
p. A88-
1 p.
|
artikel
|
| 1006 |
PSU19 NATIONWIDE UTILIZATION PATTERN OF WHOLE BRAIN RADIOTHERAPY AND STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASIS
|
Jung, S.Y.
|
|
2011
|
14 |
3 |
p. A89-
1 p.
|
artikel
|
| 1007 |
PSU8 PATTERNS OF ACUTE CLOPIDOGREL USE AND INPATIENT COSTS IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING
|
Johnston, S.S.
|
|
2011
|
14 |
3 |
p. A87-
1 p.
|
artikel
|
| 1008 |
PSU11 REDUCTION IN HEALTHCARE UTILIZATION AND EXPENDITURES IN PATIENTS TREATED WITH CATHETER ABLATION FOR ATRIAL FIBRILLATION (AF) IN THE UNITED STATES
|
Ladapo, J.A.
|
|
2011
|
14 |
3 |
p. A88-
1 p.
|
artikel
|
| 1009 |
PSU4 SURGEON'S VOLUME-OUTCOMES RELATIONSHIP FOR LOBECTOMIES AND WEDGE RESECTIONS FOR CANCER USING VIDEO-ASSISTED THORACOSCOPIC TECHNIQUES
|
David, G.
|
|
2011
|
14 |
3 |
p. A86-A87
nvt p.
|
artikel
|
| 1010 |
PSU21 THE REUSE OF SINGLE-USE SURGICAL DEVICES: EVALUATION OF THE ECONOMIC EVIDENCE
|
Emmermann, A.
|
|
2011
|
14 |
3 |
p. A90-
1 p.
|
artikel
|
| 1011 |
PSU2 USING ELECTRONIC MEDICAL RECORDS TO IDENTIFY POTENTIAL PREDICTORS FOR BARIATRIC SURGERY SUCCESS
|
Benoit, S.
|
|
2011
|
14 |
3 |
p. A86-
1 p.
|
artikel
|
| 1012 |
PSY29 A COMPARISON OF DAILY AVERAGE SUPPLY (DASUP) OF OXYCODONE AND OXYMORPHONE LONG-ACTING ORAL TABLETS
|
Rubino, M.
|
|
2011
|
14 |
3 |
p. A64-
1 p.
|
artikel
|
| 1013 |
PSY18 A DECISION ANALYSIS MODEL EXPLORING THE RESULTS OF A PHASE II TRIAL OF ELTROMBOPAG FOR PATIENTS WITH CHRONIC HEPATITIS C, CIRRHOSIS AND THROMBOCYTOPENIA
|
Schelfhout, J.
|
|
2011
|
14 |
3 |
p. A62-
1 p.
|
artikel
|
| 1014 |
PSY22 ANALYSING THE BENEFITS AND COST SAVING OF ORAL VERSUS IV FLUDARABINE FOR MANAGEMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL)
|
Zinzani, P.L.
|
|
2011
|
14 |
3 |
p. A63-
1 p.
|
artikel
|
| 1015 |
PSY5 AN INVESTIGATION INTO THE RELATIONSHIP BETWEEN OBESITY AND SKIN AND SOFT TISSUE INFECTIONS REQUIRING HOSPITALIZATION
|
Swiney, J.
|
|
2011
|
14 |
3 |
p. A59-
1 p.
|
artikel
|
| 1016 |
PSY7 A NOVEL MECHANISM OF CAPTURING POST-MARKETING SAFETY INFORMATION ON RECOMBINANT FACTOR VIIA (RFVIIA) IN THE RARE DISORDER ACQUIRED HEMOPHILIA: THE ACQUIRED HEMOPHILIA SURVEILLANCE (AHS) PROJECT
|
Lentz, S.
|
|
2011
|
14 |
3 |
p. A60-
1 p.
|
artikel
|
| 1017 |
PSY17 A PHARMACOECONOMIC EVALUATION OF ROMIPLOSTIM (NPLATE®) FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) IN MEXICO
|
Arocho, R.
|
|
2011
|
14 |
3 |
p. A62-
1 p.
|
artikel
|
| 1018 |
PSY54 APPLICATION OF THE NON-LINEAR BLINDER-OAXACA DECOMPOSITION TO STUDY RACIAL/ETHNIC DISPARITIES IN ANTI-OBESITY MEDICATION USE
|
Mehta, H.B.
|
|
2011
|
14 |
3 |
p. A69-
1 p.
|
artikel
|
| 1019 |
PSY30 A REAL-WORLD EVALUATION OF ADHERENCE AND PERSISTENCE OF WEIGHT-LOSS PHARMACOTHERAPY IN THE UNITED STATES: 2007-2010
|
Charland, S.L.
|
|
2011
|
14 |
3 |
p. A64-
1 p.
|
artikel
|
| 1020 |
PSY70 ASSOCIATION OF PROVIDER CONTINUITY WITH HOSPITALIZATION AMONG FLORIDA MEDICAID ENROLLEES WITH SICKLE CELL DISEASE (SCD)
|
Ma, Q.
|
|
2011
|
14 |
3 |
p. A71-A72
nvt p.
|
artikel
|
| 1021 |
PSY48 A WORKPLACE HEALTH PROGRAM FOR BRITISH COLUMBIA PUBLIC SERVICE AGENCY (CANADA)
|
Tarride, J.E.
|
|
2011
|
14 |
3 |
p. A68-
1 p.
|
artikel
|
| 1022 |
PSY12 BASELINE CHARACTERISTICS AND PRE–INDEX TOTAL HEALTH CARE AND RHEUMATOID ARTHRITIS-RELATED COSTS IN PATIENTS RECEIVING GOLIMUMAB THERAPY
|
Carter, C.
|
|
2011
|
14 |
3 |
p. A61-
1 p.
|
artikel
|
| 1023 |
PSY66 BIOLOGIC EXPERIENCE AND DOSING OF GOLIMUMAB PATIENTS IN MANAGED CARE
|
Carter, C.
|
|
2011
|
14 |
3 |
p. A71-
1 p.
|
artikel
|
| 1024 |
PSY11 BURDEN OF ILLNESS IN FIBROMYALGIA SYNDROME: THE PATIENTS' PERSPECTIVES
|
Lee, S.S.
|
|
2011
|
14 |
3 |
p. A60-A61
nvt p.
|
artikel
|
| 1025 |
PSY34 CALCULATING PROMIS FATIGUE ITEM BANK IRT PARAMETER ESTIMATES SPECIFIC TO PATIENTS WITH FIBROMYALGIA
|
Schilling, S.
|
|
2011
|
14 |
3 |
p. A65-
1 p.
|
artikel
|
| 1026 |
PSY45 CHARACTERISTICS OF CAREGIVERS AND THEIR EXPERIENCE ASSOCIATED WITH CONGENITAL HEMOPHILIA OF INHIBITOR PATIENTS
|
Wisniewski, T.
|
|
2011
|
14 |
3 |
p. A67-
1 p.
|
artikel
|
| 1027 |
PSY61 CHARACTERISTICS OF GOLIMUMAB UTILIZATION AND COSTS IN A SPECIALTY PHARMACY PROVIDER (SPP) SETTING
|
Ellis, L.
|
|
2011
|
14 |
3 |
p. A70-
1 p.
|
artikel
|
| 1028 |
PSY65 CHARACTERISTICS OF GOLIMUMAB UTILIZATION IN A LARGE NATIONAL PAYER DATABASE
|
Tandon, N.
|
|
2011
|
14 |
3 |
p. A71-
1 p.
|
artikel
|
| 1029 |
PSY77 COMPARISON OF OBESITY-ASSOCIATED COMORBIDITIES BETWEEN EMR AND CLAIMS DATABASES
|
Brixner, D.
|
|
2011
|
14 |
3 |
p. A73-
1 p.
|
artikel
|
| 1030 |
PSY79 CONTENT VALIDITY OF THE MULTIPLE SCLEROSIS INTERNATIONAL QOL (MUSIQOL) QUESTIONNAIRE IN IRAN, EGYPT, MOROCCO, SAUDI ARABIA AND TUNISIA
|
Trevin, A.
|
|
2011
|
14 |
3 |
p. A73-
1 p.
|
artikel
|
| 1031 |
PSY56 CONTROLLED SUBSTANCE PRESCRIBING AND UTILIZATION OF PRESCRIPTION DRUG MONITORING PROGRAMS
|
Talbert, J.
|
|
2011
|
14 |
3 |
p. A69-
1 p.
|
artikel
|
| 1032 |
PSY10 COST ANALYSIS OF ANEMIA TREATMENT WITH ERYTHROPOIESES-STIMULATING AGENTS (ESAS) IN CANCER PATIENTS RECEIVING CHEMOTHERAPY: A MULTICOUNTRY APPROACH
|
Duran, A.
|
|
2011
|
14 |
3 |
p. A60-
1 p.
|
artikel
|
| 1033 |
PSY21 COST-EFFECTIVENESS ANALISYS OF TREATMENT WITH AMFEPRAMONE (DIETHYLPROPION) IN OBESITY IN MEXICO
|
Ramirez Ramirez, M.
|
|
2011
|
14 |
3 |
p. A62-A63
nvt p.
|
artikel
|
| 1034 |
PSY15 COSTS OF CARE FOR PRIVATELY INSURED MALES WITH HEMOPHILIA IN THE UNITED STATES, 2008
|
Guh, S.
|
|
2011
|
14 |
3 |
p. A61-
1 p.
|
artikel
|
| 1035 |
PSY24 COST-UTILITY ANALYSES OF DIFFERENT ERYTROPOIETINS IN ANEMIC PATIENTS ON DIALYSIS IN RUSSIA
|
Vorobyev, P.
|
|
2011
|
14 |
3 |
p. A63-
1 p.
|
artikel
|
| 1036 |
PSY68 DEFINITIONS OF ANTI-TNF DISCONTINUATION MAY IMPACT UNDERSTANDING OF REAL-WORLD UTILIZATION PATTERNS
|
Schmeichel-Mueller, C.
|
|
2011
|
14 |
3 |
p. A71-
1 p.
|
artikel
|
| 1037 |
PSY36 DEVELOPMENT OF THE LUPUS IMPACT TRACKER: A TOOL FOR PATIENTS AND PHYSICIANS TO ASSESS AND MONITOR THE IMPACT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
|
Jolly, M.
|
|
2011
|
14 |
3 |
p. A65-A66
nvt p.
|
artikel
|
| 1038 |
PSY8 DIRECT AND INDIRECT COSTS OF PRIVATELY-INSURED PATIENTS TREATED WITH OXYMORPHONE EXTENDED-RELEASE OR OXYCODONE CONTROLLED-RELEASE TABLETS
|
Kirson, N.Y.
|
|
2011
|
14 |
3 |
p. A60-
1 p.
|
artikel
|
| 1039 |
PSY46 DISEASE SYMPTOMS, TREATMENT SATISFACTION, AND COPING STRATEGIES IN PATIENTS WITH LUPUS
|
Lerstrøm, K.
|
|
2011
|
14 |
3 |
p. A67-
1 p.
|
artikel
|
| 1040 |
PSY58 DISPARITY IN OBESITY MANAGEMENT: UNDER-TREATMENT AMONG ELDERLY POPULATION
|
Shah, A.J.
|
|
2011
|
14 |
3 |
p. A69-
1 p.
|
artikel
|
| 1041 |
PSY57 DOES CLINICAL DIAGNOSIS OF OBESITY INCREASE THE LIKELIHOOD OF RECEIVING OBESITY RELATED COUNSELING? A 2005-2008 NAMCS-NHAMCS ANALYSIS
|
Kadakia, A.
|
|
2011
|
14 |
3 |
p. A69-
1 p.
|
artikel
|
| 1042 |
PSY60 ECONOMIC CONSEQUENCES OF UNDER-UTILIZATION WITH TUMOR NECROSIS FACTOR INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS
|
Carter, C.
|
|
2011
|
14 |
3 |
p. A70-
1 p.
|
artikel
|
| 1043 |
PSY23 ECONOMIC EVALUATION OF ERYTHROPOIESIS STIMULATING AGENTS IN CRITICALLY ILL TRAUMA PATIENTS
|
Chui, B.K.Y.
|
|
2011
|
14 |
3 |
p. A63-
1 p.
|
artikel
|
| 1044 |
PSY20 ECONOMIC EVALUATION OF SEQUENTIAL ANALGESIC TREATMENT IN THE MANAGEMENT OF MODERATE ANKLE SPRAIN IN MEXICAN ADULTS
|
Arreola-Ornelas, H.
|
|
2011
|
14 |
3 |
p. A62-
1 p.
|
artikel
|
| 1045 |
PSY14 ECONOMIC IMPACT OF POTENTIAL DRUG-DRUG INTERACTIONS AMONG PATIENTS TAKING OPIOID ANALGESICS
|
Summers, K.H.
|
|
2011
|
14 |
3 |
p. A61-
1 p.
|
artikel
|
| 1046 |
PSY51 EFFECTIVENESS OF FDA'S NEW OVER-THE-COUNTER ACETAMINOPHEN LABEL WARNING REQUIREMENTS IN IMPROVING CONSUMER RISK PERCEPTION OF LIVER DAMAGE
|
Goyal, R.K.
|
|
2011
|
14 |
3 |
p. A68-
1 p.
|
artikel
|
| 1047 |
PSY42 EPIDEMIOLOGY AND QALITY OF LIFE OF ANEMIC PATIENTS ON DIALYSIS IN RUSSIA: PATIENT-REPORTED DATA
|
Vorobyev, P.
|
|
2011
|
14 |
3 |
p. A66-A67
nvt p.
|
artikel
|
| 1048 |
PSY39 EPIDEMIOLOGY OF HEREDITARY COAGULOPATHIES IN KAZAKHSTAN: PATIENT-REPORTED DATA
|
Vorobyev, P.
|
|
2011
|
14 |
3 |
p. A66-
1 p.
|
artikel
|
| 1049 |
PSY40 EPIDEMIOLOGY OF HEREDITARY COAGULOPATHIES IN UKRAINE: PATIENT-REPORTED DATA
|
Vorobyev, P.
|
|
2011
|
14 |
3 |
p. A66-
1 p.
|
artikel
|
| 1050 |
PSY78 ESTIMATING THE BMI-MORTALITY RELATION USING FRACTIONAL POLYNOMIALS
|
Wong, E.
|
|
2011
|
14 |
3 |
p. A73-
1 p.
|
artikel
|
| 1051 |
PSY33 EXPLORING THE FACTOR STRUCTURE OF THE PROMIS FATIGUE ITEM BANK IN PATIENTS WITH FIBROMYALGIA
|
Schilling, S.
|
|
2011
|
14 |
3 |
p. A65-
1 p.
|
artikel
|
| 1052 |
PSY28 FACTORS LEADING TO HIGH HEALTH CARE EXPENDITURE AMONG OBESE INDIVIDUALS IN THE UNITED STATES
|
Patel, J.G.
|
|
2011
|
14 |
3 |
p. A64-
1 p.
|
artikel
|
| 1053 |
PSY64 GE CENTRICITY® ELECTRONIC MEDICAL RECORDS STUDY: COMORBIDITIES AND BIOLOGIC EXPERIENCE AMONG PATIENTS RECEIVING GOLIMUMAB
|
Tandon, N.
|
|
2011
|
14 |
3 |
p. A70-A71
nvt p.
|
artikel
|
| 1054 |
PSY71 HEALTH AND FUNCTIONAL STATUS FOR INDIVIDUALS WITH THROMBOCYTOPENIA IN THE UNITED STATES: EVIDENCE FROM NHANES
|
Kauf, T.
|
|
2011
|
14 |
3 |
p. A72-
1 p.
|
artikel
|
| 1055 |
PSY9 HEALTH CONSEQUENCES AND COSTS OF TACHOSIL® AS HAEMOSTATIC TREATMENT IN LIVER SURGERY VERSUS TISSUCOL®: A RETROSPECTIVE OBSERVATIONAL COHORT STUDY
|
Ortega, A.
|
|
2011
|
14 |
3 |
p. A60-
1 p.
|
artikel
|
| 1056 |
PSY41 HEALTH-RELATED QUALITY OF LIFE IN KAZAKHSTAN PATIENTS WITH HEREDITARY COAGULOPATHIES
|
Vorobyev, P.
|
|
2011
|
14 |
3 |
p. A66-
1 p.
|
artikel
|
| 1057 |
PSY43 HEALTH-RELATED QUALITY OF LIFE IN UKRAINE PATIENTS WITH HEREDITARY COAGULOPATHIES
|
Vorobyev, P.
|
|
2011
|
14 |
3 |
p. A67-
1 p.
|
artikel
|
| 1058 |
PSY31 HEMOPHILIA A: PATIENT IMPACT AND ECONOMIC BURDEN OF THE DISEASE
|
Strandberg-Larsen, M.
|
|
2011
|
14 |
3 |
p. A64-A65
nvt p.
|
artikel
|
| 1059 |
PSY32 HOW DO MINIMALLY IMPORTANT DIFFERENCES VALUE OUTCOMES?
|
Suh, J.K.
|
|
2011
|
14 |
3 |
p. A65-
1 p.
|
artikel
|
| 1060 |
PSY26 IMPACT OF HYPONATREMIA ON PATIENT OUTCOMES AND HEALTH CARE RESOURCE UTILIZATION IN HOSPITALIZED PATIENTS
|
Deitelzweig, S.
|
|
2011
|
14 |
3 |
p. A63-A64
nvt p.
|
artikel
|
| 1061 |
PSY59 IMPACT OF OBESITY ON AGE-SPECIFIC PREVALENCE OF CHRONIC DISEASES IN THE UNITED STATES
|
Patel, J.G.
|
|
2011
|
14 |
3 |
p. A69-A70
nvt p.
|
artikel
|
| 1062 |
PSY63 LONGITUDINAL ANALYSIS OF INFLIXIMAB DOSING AND INFUSION INTERVALS ACROSS 30 INFUSIONS
|
Carter, C.
|
|
2011
|
14 |
3 |
p. A70-
1 p.
|
artikel
|
| 1063 |
PSY69 MODELING THE IMPACT OF REFILL OR ADMINISTRATION GAPS ON PATIENT DRUG LEVELS OF THE TNF-ALPHA INHIBITORS ETANERCEPT AND INFLIXIMAB
|
Ingham, M.
|
|
2011
|
14 |
3 |
p. A71-
1 p.
|
artikel
|
| 1064 |
PSY55 NATIONAL TRENDS IN ANTI-OBESITY MEDICATION USE FROM 2002 TO 2007
|
Mehta, H.B.
|
|
2011
|
14 |
3 |
p. A69-
1 p.
|
artikel
|
| 1065 |
PSY3 OPIOIDS IN NON-MALIGNANT PAIN: ARE THEY EQUIVALENT IN SAFETY PROFILE? A NETWORK META-ANALYSIS
|
Siddiqui, M.K.
|
|
2011
|
14 |
3 |
p. A59-
1 p.
|
artikel
|
| 1066 |
PSY44 PAIN MANAGEMENT: IMPACT ON QUALITY OF LIFE
|
Bertin, P.
|
|
2011
|
14 |
3 |
p. A67-
1 p.
|
artikel
|
| 1067 |
PSY73 PAIN MEDICATION USE AND DETERMINANTS OF OPIOIDS PRESCRIBING IN THE UNITED STATES OUTPATIENT SETTINGS
|
Rasu, R.
|
|
2011
|
14 |
3 |
p. A72-
1 p.
|
artikel
|
| 1068 |
PSY38 PATIENT-REPORTED OUTCOMES IN SUBJECTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY: PAIN DESCRIPTION AND QUALITY OF LIFE
|
Ko, K.S.
|
|
2011
|
14 |
3 |
p. A66-
1 p.
|
artikel
|
| 1069 |
PSY62 PERCEIVED BENEFITS AND DISADVANTAGES OF INTRAVENOUS (IV) BIOLOGIC THERAPY AMONG PATIENTS WITH IMMUNOLOGY CONDITIONS
|
Bolge, S.
|
|
2011
|
14 |
3 |
p. A70-
1 p.
|
artikel
|
| 1070 |
PSY81 PERCEPTIONS ABOUT 'RAPID' WARFARIN REVERSAL WITH FRESH FROZEN PLASMA TO REDUCE THE INR: A NOVEL SURVEY METHODOLOGY
|
Petrozzino, J.
|
|
2011
|
14 |
3 |
p. A74-
1 p.
|
artikel
|
| 1071 |
PSY52 POTENTIAL DRUG-DRUG INTERACTIONS (DDIS) WITH PAIN MEDICATIONS AMONG PATIENTS WITH BACK AND NECK PAIN DIAGNOSES CATEGORIZED INTO NOCICEPTIVE, NEUROPATHIC OR MIXED PAIN COHORTS
|
Kozma, C.
|
|
2011
|
14 |
3 |
p. A68-
1 p.
|
artikel
|
| 1072 |
PSY49 PREDICTORS OF OBESITY TREATMENT (COUNSELING OR PHARMACOTHERAPY) IN AMBULATORY SETTINGS
|
Mehta, H.B.
|
|
2011
|
14 |
3 |
p. A68-
1 p.
|
artikel
|
| 1073 |
PSY50 PRESCRIPTION MONITORING PROGRAMS' UTILIZATION
|
Fleming, M.L.
|
|
2011
|
14 |
3 |
p. A68-
1 p.
|
artikel
|
| 1074 |
PSY75 PREVALENCE RATIOS AGAINST ODDS RATIOS AS EFFECT MEASURES IN A CROSS-SECTIONAL STUDY OF OBESITY AND ITS CHRONIC COMORBID CONDITIONS
|
Patel, J.G.
|
|
2011
|
14 |
3 |
p. A72-A73
nvt p.
|
artikel
|
| 1075 |
PSY80 PRIORITIZATION AND WEIGHTING OF PATIENT-RELEVANT ENDPOINTS (PRES) AS PART OF THE IQWIGS EFFICIENCY FRONTIER METHOD IN GERMANY
|
Mühlbacher, A.
|
|
2011
|
14 |
3 |
p. A73-A74
nvt p.
|
artikel
|
| 1076 |
PSY16 PROJECTING THE LIFETIME ECONOMIC COSTS OF OBESITY: A BMI TRAJECTORY-BASED MODEL
|
Wang, B.C.M.
|
|
2011
|
14 |
3 |
p. A61-A62
nvt p.
|
artikel
|
| 1077 |
PSY27 REAL-WORLD EVALUATION OF HEALTH CARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY (PDPN) TREATED WITH PREGABALIN OR GABAPENTIN
|
Udall, M.
|
|
2011
|
14 |
3 |
p. A64-
1 p.
|
artikel
|
| 1078 |
PSY67 REASONS FOR INITIATING INTRAVENOUS BIOLOGIC THERAPY AMONG PATIENTS WITH IMMUNOLOGY CONDITIONS: SUBSET ANALYSIS OF PRIOR SUBCUTANEOUS INJECTION (SQ) USERS AND IMPLICATIONS FOR SHARED DECISION MAKING
|
Bolge, S.
|
|
2011
|
14 |
3 |
p. A71-
1 p.
|
artikel
|
| 1079 |
PSY25 RELATIONSHIP BETWEEN MONTHLY OUT-OF-POCKET HEALTHCARE COSTS AND WORK PRODUCTIVITY AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
|
Naim, A.
|
|
2011
|
14 |
3 |
p. A63-
1 p.
|
artikel
|
| 1080 |
PSY1 SEVERE RENAL, HEPATIC AND GASTROINTESTINAL EVENTS ASSOCIATED WITH DEFERASIROX IN PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA
|
Huang, W.F.
|
|
2011
|
14 |
3 |
p. A59-
1 p.
|
artikel
|
| 1081 |
PSY2 THE ASSOCIATION BETWEEN THERAPY WITH ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND HEMOGLOBIN LEVEL
|
Chodick, G.
|
|
2011
|
14 |
3 |
p. A59-
1 p.
|
artikel
|
| 1082 |
PSY19 THE COST-EFFECTIVENESS OF BORTEZOMIB PLUS MELPHALAN AND PREDNISONE VERSUS LENALIDOMIDE PLUS MELPHALAN AND PREDNISONE WITH CONTINUOUS LENALIDOMIDE MAINTENANCE TREATMENT FOR THE INITIAL TREATMENT OF MULTIPLE MYELOMA IN THE UNITED STATES
|
Wang, S.T.
|
|
2011
|
14 |
3 |
p. A62-
1 p.
|
artikel
|
| 1083 |
PSY13 THE COST OF OBESITY AND ITS MAJOR COMORBIDITIES: ANALYSIS FROM A COMMERCIAL CLAIMS DATABASE
|
Padula, W.V.
|
|
2011
|
14 |
3 |
p. A61-
1 p.
|
artikel
|
| 1084 |
PSY37 THE PAIN MANAGEMENT IS ALWAYS A PUBLIC HEALTH CHALLENGE
|
Bertin, P.
|
|
2011
|
14 |
3 |
p. A66-
1 p.
|
artikel
|
| 1085 |
PSY6 TRANSFUSIONAL IRON OVERLOAD (TIO) MONITORING AND TREATMENT: FINDINGS FROM AN ELECTRONIC MEDICAL RECORDS REVIEW STUDY AT THE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE
|
Duh, M.S.
|
|
2011
|
14 |
3 |
p. A59-A60
nvt p.
|
artikel
|
| 1086 |
PSY74 TREATMENT CHOICE FOR PAIN MANAGEMENT IN NURSING HOME HOSPICE/PALLIATIVE CARE RESIDENTS IN THE UNITED STATES
|
Agrawal, R.
|
|
2011
|
14 |
3 |
p. A72-
1 p.
|
artikel
|
| 1087 |
PSY76 TREATMENT OF CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS) KNOWLEDGE STUDY (TOCKS): NOVEL DATA COLLECTION, VIEWING AND DYNAMIC REPORTING MECHANISM
|
Arnold, R.J.
|
|
2011
|
14 |
3 |
p. A73-
1 p.
|
artikel
|
| 1088 |
PSY4 TRENDS IN HYPONATREMIA MANAGEMENT AND ASSOCIATED OUTCOMES IN HOSPITAL SETTINGS: INTERIM RESULTS FROM AN OBSERVATIONAL, PROSPECTIVE, MULTI-CENTER, GLOBAL REGISTRY IN HOSPITALIZED PATIENTS
|
Dasta, J.F.
|
|
2011
|
14 |
3 |
p. A59-
1 p.
|
artikel
|
| 1089 |
PSY35 VALIDATION OF THE LUPUS IMPACT TRACKER
|
Jolly, M.
|
|
2011
|
14 |
3 |
p. A65-
1 p.
|
artikel
|
| 1090 |
PSY72 VARIATION BY AGE IN HEALTH-RELATED QUALITY OF LIFE OF PATIENTS INITIATING TREATMENT FOR MYELODYSPLASTIC SYNDROMES
|
Pashos, C.
|
|
2011
|
14 |
3 |
p. A72-
1 p.
|
artikel
|
| 1091 |
PSY47 WILLINGNESS TO PAY (WTP) FOR WEIGHT LOSS COACHING: RESULTS FROM THE POWER TRIAL
|
Alavi, R.
|
|
2011
|
14 |
3 |
p. A67-A68
nvt p.
|
artikel
|
| 1092 |
PUK14 A MARKOV MODEL COMPARING SACRAL NEUROMODULATION AND BOTULINUM TOXIN-A FOR MEDICARE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER REFRACTORY TO CONSERVATIVE CARE
|
Ganz, M.
|
|
2011
|
14 |
3 |
p. A76-A77
nvt p.
|
artikel
|
| 1093 |
PUK13 COST-EFFECTIVENESS ANALYSIS OF THE EARLY CONVERSION OF TACROLIMUS TO MTOR INHIBITORS IN PATIENTS WITH RENAL TRANSPLANTATION
|
Gamboa, O.
|
|
2011
|
14 |
3 |
p. A76-
1 p.
|
artikel
|
| 1094 |
PUK12 COST-EFFECTIVENESS OF TOLTERODINE AS TREATMENT FOR OVERACTIVE BLADDER (OAB) IN ADULT MEXICAN PATIENTS
|
Arreola-Ornelas, H.
|
|
2011
|
14 |
3 |
p. A76-
1 p.
|
artikel
|
| 1095 |
PUK16 COST-EFFECTIVENESS OF VALGANCICLOVIR 200 DAYS PROPHYLAXIS VERSUS 100 DAYS PROPHYLAXIS IN KIDNEY TRANSPLANT PATIENTS AT HIGH-RISK FOR DEVELOPING CYTOMEGALOVIRUS DISEASE
|
Vicente, C.
|
|
2011
|
14 |
3 |
p. A77-
1 p.
|
artikel
|
| 1096 |
PUK4 CUMULATIVE EXPOSURE TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) AND THE PROGRESSION OF CHRONIC KIDNEY DISEASE (CKD)
|
Yarger, S.
|
|
2011
|
14 |
3 |
p. A74-A75
nvt p.
|
artikel
|
| 1097 |
PUK3 DRUG-INDUCED ACUTE RENAL FAILURE USING THE FDA ADVERSE EVENT REPORTING SYSTEM DATABASE
|
Alhammad, A.M.
|
|
2011
|
14 |
3 |
p. A74-
1 p.
|
artikel
|
| 1098 |
PUK2 DUTASTERIDE FOR BENIGN PROSTATIC HYPERPLASIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
|
Park, T.
|
|
2011
|
14 |
3 |
p. A74-
1 p.
|
artikel
|
| 1099 |
PUK20 EARLY DETECTION, SCREENING, AND MANAGEMENT OF CHRONIC KIDNEY DISEASE AMONG ACTIVELY EMPLOYED – AN INTEGRATED POPULATION HEALTH MANAGEMENT APPROACH
|
Harshman, R.
|
|
2011
|
14 |
3 |
p. A78-
1 p.
|
artikel
|
| 1100 |
PUK7 ECONOMIC EVALUATION OF CINACALCET VERSUS STANDARD TREATMENT IN PATIENTS WITH SECONDARY HYPERPARATHYROIDISM IN MEXICO
|
Arocho, R.
|
|
2011
|
14 |
3 |
p. A75-
1 p.
|
artikel
|
| 1101 |
PUK1 INCIDENCE AND 30-DAY MORTALITY OF COMMUNITY ACQUIRED PNEUMONIA (CAP) IN THE MEDICARE FEE-FOR-SERVICE (FFS) POPULATION
|
Rubin, J.L.
|
|
2011
|
14 |
3 |
p. A74-
1 p.
|
artikel
|
| 1102 |
PUK19 KIT73: PRELIMINARY REPORTS OF IMMUNOSUPRESSANT THERAPY PATTERNS IN A COHORT OF POST KIDNEY TRANSPLANT PATIENTS IN BRAZIL
|
Carvalho, D.D.B.M.
|
|
2011
|
14 |
3 |
p. A77-A78
nvt p.
|
artikel
|
| 1103 |
PUK8 KIT73 STUDY: DOES TYPE OF DONOR INFLUENCE LONG-TERM COSTS OF CARE? RESULTS FROM POST-KIDNEY TRANSPLANT PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM (SUS)
|
Tedesco-Silva, H.J.
|
|
2011
|
14 |
3 |
p. A75-
1 p.
|
artikel
|
| 1104 |
PUK10 KIT73 STUDY: RELATIONSHIP BETWEEN COSTS OF CARE AND 12-MONTH GLOMERULAR FILTRATION RATES IN POST-KIDNEY TRANSPLANT PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM (SUS)
|
David-Neto, E.
|
|
2011
|
14 |
3 |
p. A76-
1 p.
|
artikel
|
| 1105 |
PUK22 LEVELING THE PLAYING FIELD: A CASE STUDY ON TECHNICAL PRECISION IN COMPARATIVE EFFECTIVENESS RESEARCH FOR CLINICALLY LOCALIZED PROSTATE CANCER (PC)
|
Hughes, K.E.
|
|
2011
|
14 |
3 |
p. A78-
1 p.
|
artikel
|
| 1106 |
PUK6 LOW-MOLECULAR-WEIGHT HEPARIN IN CHRONIC HEMODIALYSIS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
|
Burke, N.
|
|
2011
|
14 |
3 |
p. A75-
1 p.
|
artikel
|
| 1107 |
PUK9 MEDICAL CARE SPENDING ASSOCIATED WITH CHRONIC KIDNEY DISEASE BY STAGE OF DISEASE: A POPULATION-BASED STUDY
|
Taylor, T.N.
|
|
2011
|
14 |
3 |
p. A75-
1 p.
|
artikel
|
| 1108 |
PUK23 METHODOLOGICAL CONSIDERATIONS FOR COST-EFFECTIVENESS ANALYSIS OF ONABOTULINUMTOXINA IN PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY
|
Globe, D.
|
|
2011
|
14 |
3 |
p. A78-
1 p.
|
artikel
|
| 1109 |
PUK21 PATIENT CHARACTERISTICS ASSOCIATED WITH INITIATION OF OVERACTIVE BLADDER (OAB) DISCUSSION WITH A PHYSICIAN
|
Botros, S.
|
|
2011
|
14 |
3 |
p. A78-
1 p.
|
artikel
|
| 1110 |
PUK15 THE COST-EFFECTIVENESS OF LANTHANUM CARBONATE IN THE TREATMENT OF HYPERPHOSPHATEMIA IN DIALYSIS PATIENTS FROM A CANADIAN PERSPECTIVE
|
Vegter, S.
|
|
2011
|
14 |
3 |
p. A77-
1 p.
|
artikel
|
| 1111 |
PUK18 THE IMPACT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) ON PATIENTS' HEALTH RELATED QUALITY OF LIFE (HRQOL): DEVELOPMENT OF A CONCEPTUAL FRAMEWORK
|
Cole, J.C.
|
|
2011
|
14 |
3 |
p. A77-
1 p.
|
artikel
|
| 1112 |
PUK5 TREATMENT PATTERNS IN OVERACTIVE BLADDER: REAL-WORLD PATIENT POPULATION
|
Ellsworth, P.
|
|
2011
|
14 |
3 |
p. A75-
1 p.
|
artikel
|
| 1113 |
PUK11 UPDATED ECONOMIC ANALYSIS OF FESOTERODINE RELATIVE TO TOLTERODINE AND SOLIFENACIN FOR THE TREATMENT OF OVERACTIVE BLADDER: THE SWEDISH PERSPECTIVE
|
Lee, R.
|
|
2011
|
14 |
3 |
p. A76-
1 p.
|
artikel
|
| 1114 |
PUK24 USE OF BIOMARKERS IN PROPENSITY SCORE MATCHING TO MITIGATE CHANNELING BIAS IN A RETROSPECTIVE COHORT OF ESRD PATIENTS
|
Wilson, S.M.
|
|
2011
|
14 |
3 |
p. A78-A79
nvt p.
|
artikel
|
| 1115 |
PUK17 UTILIZATION AND ECONOMIC IMPACT OF IV IRON AND ERYTHROPOIESIS STIMULATING AGENTS IN CHRONIC KIDNEY DISEASE PATIENTS: A MULTI-HOSPITAL STUDY
|
Joshi, A.D.
|
|
2011
|
14 |
3 |
p. A77-
1 p.
|
artikel
|
| 1116 |
QA1 COST-EFFECTIVENESS OF DUTASTERIDE AS A CHEMOPREVENTION IN PROSTATE CANCER: REDUCE WITHIN-TRIAL ANALYSIS
|
Earnshaw, S.R.
|
|
2011
|
14 |
3 |
p. A11-
1 p.
|
artikel
|
| 1117 |
QA2 CROSS-WALKING CANCER-SPECIFIC INSTRUMENTS TO THE EQ-5D AND SF-6D
|
Teckle, P.
|
|
2011
|
14 |
3 |
p. A11-
1 p.
|
artikel
|
| 1118 |
QA3 DOES COST-EFFECTIVENESS ANALYSIS DISCRIMINATE AGAINST PATIENTS WITH SHORTER LIFE EXPECTANCY?
|
Paulden, M.
|
|
2011
|
14 |
3 |
p. A12-
1 p.
|
artikel
|
| 1119 |
QA4 IS THE AIM OF THE HEALTH CARE SYSTEM TO MAXIMISE QALYS? AN INVESTIGATION OF ‘WHAT ELSE MATTERS’ IN THE NHS
|
Praet, C.
|
|
2011
|
14 |
3 |
p. A12-
1 p.
|
artikel
|
| 1120 |
SB4 A METHODOLOGY FOR ASSESSING TREATMENT EFFECT IN THE PRESENCE OF DISEASE SEVERITY AND COMORBIDITY IN RETROSPECTIVE OBSERVATIONAL STUDIES
|
Kiri, V.A.
|
|
2011
|
14 |
3 |
p. A5-
1 p.
|
artikel
|
| 1121 |
SB1 COMPARISON OF DIFFERENCE-IN-DIFFERENCE, PROPENSITY SCORE MATCHING AND INSTRUMENTAL VARIABLES IN ESTIMATING COST DIFFERENCES BETWEEN TWO COHORTS
|
Cao, Z.
|
|
2011
|
14 |
3 |
p. A4-
1 p.
|
artikel
|
| 1122 |
SB3 INNOVATIVE DESIGN FOR A COMPARATIVE EFFECTIVENESS STUDY OF SCHIZOPHRENIA TREATMENTS: ANALYSIS OF RECORD REVIEW DATA INCORPORATING RANDOMIZATION AND PROPENSITY SCORE MATCHING
|
McCarrier, K.P.
|
|
2011
|
14 |
3 |
p. A4-A5
nvt p.
|
artikel
|
| 1123 |
SB2 ZEROS AND NON-REPORTED HEALTH CARE AND WORKPLACE PRODUCTIVITY DATA: AN APPLICATION OF TWO-STAGE ESTIMATION TECHNIQUES MEASURING INPATIENT COSTS AND ABSENTEEISM ASSOCIATED WITH LOW BACK AND NECK PAIN
|
Simons, W.R.
|
|
2011
|
14 |
3 |
p. A4-
1 p.
|
artikel
|
| 1124 |
Table of Contents
|
|
|
2011
|
14 |
3 |
p. i-iv
nvt p.
|
artikel
|
Tijdschrift beschrijving